3,3'-Diaminobenzidine (3,3 Diaminobenzidine)

Subscribe to Selected New Research on 3,3'-Diaminobenzidine

13 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Also Known As:

3,3 Diaminobenzidine; Diaminobenzidine, 3,3; 3,3' Diaminobenzidine; 3,3-Diaminobenzidine; Diaminobenzidine, 3,3'; (1,1'-Biphenyl)-3,3',4,4'-tetramine

Bio-Agent Context: Research Results

Organic Chemicals: 40

Hydrocarbons: 382

Cyclic Hydrocarbons: 2

Aromatic Hydrocarbons: 115

Benzene Derivatives: 9

Biphenyl Compounds: 1

3,3'-Diaminobenzidine: 13

Related Diseases

1.	Neoplasms (Cancer) 09/01/2004 - "METHODS: One hundred and twenty-five SD rats fed on 3,3'-diaminobenzidine (DAB) to construct HCC models were divided into control group, cancer-inducing group and UTI intervention group" 06/01/2008 - "Samples then underwent immunohistochemistry processing for ordinal qualitative analysis of osteoprotegerin (OPG), the RANK ligant (RANKL; a tumor-related necrosis factor receptor family), and osteocalcin protein immunolabels, as detected by the immunoperoxidase method and revealed with 3,3-diaminobenzidine" Get all the results and reference details, order at left...
2.	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/01/1998 - "The methods, applied to an untreated squamous carcinoma of the pharynx, allow direct comparison of light microscopic localization of exposed nucleosomal histones using 3,3'-diaminobenzidine (DAB) and silver-enhanced techniques with a colloidal gold-based anti-histone technique at the electron microscope level" 07/01/2005 - "METHODS: Formalin-fixed, paraffin-embedded sections of oral lymphangiomas (n = 3), oral hemangiomas (n = 7), and oral squamous cell carcinomas (OSCC, n = 46) were double immunostained with D2-40 and anti-CD34 monoclonal antibodies (MoAb) using ENVISION-polymer technique with 5-bromo-4-chloro-3-indoxyl-phosphate (BCIP)/nitroblue tetrazolium chloride (NBT) and 3,3'-diaminobenzidine (DAB) as color reagents, respectively" Get all the results and reference details, order at left...
3.	Closed Head Injuries 06/01/2007 - "MATERIALS AND METHODS: We inflicted closed head trauma to male Sprague-Dawley rats and visualized ETrA and ETrB immunoreactivity with 3,3'-diaminobenzidine" Get all the results and reference details, order at left...
4.	Acute Myelomonocytic Leukemia 01/01/1992 - "We have previously reported in two cases of acute myelomonocytic leukemia (M4) that there was a great difference between 3,3'-diaminobenzidine (DAB) and 3-amino 9-ethyl carbazole (3AC) as substrates for PO reaction" Get all the results and reference details, order at left...
5.	Reperfusion Injury 01/01/1988 - "Reperfusion injury was studied in dog myocardium using a transmission electron microscope and 3,3'-diaminobenzidine (DAB) to locate areas of peroxidatic activity" Get all the results and reference details, order at left...
15 Diseases and 13 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Polymers
2.	Peroxidase (Myeloperoxidase)
3.	Osteoprotegerin
4.	Gold Colloid (Colloidal Gold)
5.	Osteocalcin
6.	3,3'-Dichlorobenzidine
7.	Sucrose (Saccharose)
8.	Silver
9.	Paraffin
10.	Oxygen
22 Drugs and Important Bio-Agents and 8 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>